SFT2D2 Antikörper (N-Term)

Produktnummer ABIN954770

Produktdetails anti-SFT2D2 Antikörper

Target: SFT2D2 (SFT2 Domain Containing 2 (SFT2D2))

Bindungsspezifität: AA 1-30, N-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SFT2D2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Enzyme Immunoassay (EIA)

Spezifität: Recognizes SFT2D2 (N-term).

Aufreinigung: Protein A column followed by peptide Affinity purification

Immunogen: KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of Human SFT2D2 Genename: SFT2D2

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) Sodium Azide as preservative

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu SFT2D2

Target: SFT2D2 (SFT2 Domain Containing 2 (SFT2D2))

Abstract: SFT2D2 Produkte

Synonyme: UNQ512 antikoerper, dJ747L4.C1.2 antikoerper, 2010005O13Rik antikoerper, AI506168 antikoerper, AW561909 antikoerper, cI-45 antikoerper, RGD1310623 antikoerper, sft2d2 antikoerper, SFT2 domain containing 2 antikoerper, SFT2 domain containing 2 L homeolog antikoerper, SFT2D2 antikoerper, Sft2d2 antikoerper, sft2d2.L antikoerper

Hintergrund: PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. L-alpha-1-palmitoyl-2-linoleoyl phosphatidylethanolamine is more efficiently hydrolyzed than the other phospholipids examined.Synonyms: SFT2 domain-containing protein 2, Vesicle transport protein SFT2B

Gen-ID: 375035

NCBI Accession: NP_955376